Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Quantum Immunologics
company
About
Quantum Immunologics is engaged in the research, development, and production of immunologic treatment systems for breast cancers.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $2.20M
- Industries
- Biotechnology,Developer Platform,Health Diagnostics
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Quantum Immunologics, Inc., a biotechnology company, engages in the research, development, and production of immunologic treatment systems for breast cancer. Its products include individualized cancer immunotherapy system, a system in which blood drawn from a patient is treated with a process and cells are injected back into the patient; cancer monitoring test that uses cancer immunotherapy to monitor blood levels of the immune response in a patient following treatment; and cancer screening test, a blood test. The company is based in Tampa, Florida.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2.20M
Quantum Immunologics has raised a total of
$2.20M
in funding over 2 rounds. Their latest funding was raised on
Sep 15, 2009 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 15, 2009 | Series A | $2.20M | 1 |
Mentor Capital Partners
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Quantum Immunologics is funded by 1 investors.
Mentor Capital Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Mentor Capital Partners
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
